Franklin Resources, Inc. 13D and 13G filings for Revance Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-31 1:20 pm Sale | 2024-09-30 | 13G | Revance Therapeutics, Inc. RVNC | FRANKLIN RESOURCES INC BEN | 4,784,658 4.600% | -1,323,619 (-21.67%) | Filing |
| 2024-02-06 1:58 pm Purchase | 2023-12-31 | 13G | Revance Therapeutics, Inc. RVNC | FRANKLIN RESOURCES INC BEN | 6,108,277 6.800% | 4,352,414 (+247.88%) | Filing |
| 2021-02-02 2:44 pm Sale | 2020-12-31 | 13G | Revance Therapeutics, Inc. RVNC | FRANKLIN RESOURCES INC BEN | 1,755,863 2.600% | -1,827,109 (-50.99%) | Filing |